Clinical guideline highlights for the hospitalist: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy

Link to article at PubMed

J Hosp Med. 2023 Apr 11. doi: 10.1002/jhm.13097. Online ahead of print.


Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update RELEASE DATE: November 1, 2021 PRIOR VERSION(S): February 14, 2018 DEVELOPER: American Society of Clinical Oncology FUNDING SOURCE: American Society of Clinical Oncology TARGET POPULATION: Adult patients with cancer receiving treatment with immune checkpoint blockade inhibitors alone.

PMID:37039096 | DOI:10.1002/jhm.13097

Leave a Reply

Your email address will not be published. Required fields are marked *